These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 29496051)

  • 21. Predictors of overall survival in human papillomavirus-associated oropharyngeal cancer using the National Cancer Data Base.
    Amini A; Jasem J; Jones BL; Robin TP; McDermott JD; Bhatia S; Raben D; Jimeno A; Bowles DW; Karam SD
    Oral Oncol; 2016 May; 56():1-7. PubMed ID: 27086480
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 'Good cancer gone bad': a narrative review of HPV oropharyngeal cancer and potential poor outcomes.
    Alabi O; O'Neill JP
    Eur Arch Otorhinolaryngol; 2020 Aug; 277(8):2185-2191. PubMed ID: 32333138
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Paraneoplastic Leukocytosis and Thrombocytosis as Prognostic Biomarkers in Non-small Cell Lung Cancer].
    Boddu P; Villlines D; Aklilu M
    Zhongguo Fei Ai Za Zhi; 2016 Nov; 19(11):725-730. PubMed ID: 27866514
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The role of HPV on the risk of second primary neoplasia in patients with oropharyngeal carcinoma.
    Martel M; Alemany L; Taberna M; Mena M; Tous S; Bagué S; Castellsagué X; Quer M; León X
    Oral Oncol; 2017 Jan; 64():37-43. PubMed ID: 28024722
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ki67 Expression has Prognostic Significance in Relation to Human Papillomavirus Status in Oropharyngeal Squamous Cell Carcinoma.
    Liu J; Zhang M; Rose B; Veillard AS; Jones D; Zhang X; Soon Lee C; Milross C; Hong A
    Ann Surg Oncol; 2015; 22(6):1893-900. PubMed ID: 25404475
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Refining risk stratification for locoregional failure after chemoradiotherapy in human papillomavirus-associated oropharyngeal cancer.
    Vainshtein JM; Spector ME; McHugh JB; Wong KK; Walline HM; Byrd SA; Komarck CM; Ibrahim M; Stenmark MH; Prince ME; Bradford CR; Wolf GT; McLean S; Worden FP; Chepeha DB; Carey T; Eisbruch A
    Oral Oncol; 2014 May; 50(5):513-9. PubMed ID: 24565983
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CT-based volumetric tumor growth velocity: A novel imaging prognostic indicator in oropharyngeal cancer patients receiving radiotherapy.
    Perni S; Mohamed AS; Scott J; Enderling H; Garden AS; Gunn GB; Rosenthal DI; Fuller CD
    Oral Oncol; 2016 Dec; 63():16-22. PubMed ID: 27938995
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of Smoking on Outcomes of HPV-related Oropharyngeal Cancer Treated with Primary Radiation or Surgery.
    Vawda N; Banerjee RN; Debenham BJ
    Int J Radiat Oncol Biol Phys; 2019 Apr; 103(5):1125-1131. PubMed ID: 30513378
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nodal status is not a prognostic factor in patients with HPV-positive oral/oropharyngeal tumors.
    Klozar J; Koslabova E; Kratochvil V; Salakova M; Tachezy R
    J Surg Oncol; 2013 May; 107(6):625-33. PubMed ID: 23192334
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The applicability of new TNM classification for humanpapilloma virus-related oropharyngeal cancer in the 8th edition of the AJCC/UICC TNM staging system in Japan: A single-centre study.
    Sano D; Yabuki K; Arai Y; Tanabe T; Chiba Y; Nishimura G; Takahashi H; Yamanaka S; Oridate N
    Auris Nasus Larynx; 2018 Jun; 45(3):558-565. PubMed ID: 28760331
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Leukocytosis and neutrophilia predict outcome in locally advanced esophageal cancer treated with definitive chemoradiation.
    Schernberg A; Moureau-Zabotto L; Rivin Del Campo E; Escande A; Ducreux M; Nguyen F; Goere D; Chargari C; Deutsch E
    Oncotarget; 2017 Feb; 8(7):11579-11588. PubMed ID: 28086222
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prognostic value of maximum standardized uptake value measured by pretreatment 18F-FDG PET/CT in locally advanced head and neck squamous cell carcinoma.
    Cacicedo J; Fernandez I; Del Hoyo O; Navarro A; Gomez-Iturriaga A; Pijoan JI; Martinez-Indart L; Escudero J; Gomez-Suarez J; de Zarate RO; Perez JF; Bilbao P; Rades D
    Clin Transl Oncol; 2017 Nov; 19(11):1337-1349. PubMed ID: 28540535
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High levels of tissue inhibitor of metalloproteinase-1 (TIMP-1) in the serum are associated with poor prognosis in HPV-negative squamous cell oropharyngeal cancer.
    Carpén T; Sorsa T; Jouhi L; Tervahartiala T; Haglund C; Syrjänen S; Tarkkanen J; Mohamed H; Mäkitie A; Hagström J; Mattila PS
    Cancer Immunol Immunother; 2019 Aug; 68(8):1263-1272. PubMed ID: 31240326
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Extracapsular extension is associated with worse distant control and progression-free survival in patients with lymph node-positive human papillomavirus-related oropharyngeal carcinoma.
    Shevach J; Bossert A; Bakst RL; Liu J; Misiukiewicz K; Beyda J; Miles BA; Genden E; Posner MR; Gupta V
    Oral Oncol; 2017 Nov; 74():56-61. PubMed ID: 29103752
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Predictors of oropharyngeal cancer survival in Europe.
    Anantharaman D; Billot A; Waterboer T; Gheit T; Abedi-Ardekani B; Lagiou P; Lagiou A; Ahrens W; Holcátová I; Merletti F; Kjaerheim K; Polesel J; Simonato L; Alemany L; Mena Cervigon M; Macfarlane TV; Znaor A; Thomson PJ; Robinson M; Canova C; Conway DI; Wright S; Healy CM; Toner ME; Pawlita M; Tommasino M; Brennan P
    Oral Oncol; 2018 Jun; 81():89-94. PubMed ID: 29884419
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Surgical salvage improves overall survival for patients with HPV-positive and HPV-negative recurrent locoregional and distant metastatic oropharyngeal cancer.
    Guo T; Qualliotine JR; Ha PK; Califano JA; Kim Y; Saunders JR; Blanco RG; D'Souza G; Zhang Z; Chung CH; Kiess A; Gourin CG; Koch W; Richmon JD; Agrawal N; Eisele DW; Fakhry C
    Cancer; 2015 Jun; 121(12):1977-84. PubMed ID: 25782027
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Baseline Peripheral Blood Leukocytosis Is Negatively Correlated With T-Cell Infiltration Predicting Worse Outcome in Colorectal Cancers.
    Hu X; Li YQ; Li QG; Ma YL; Peng JJ; Cai SJ
    Front Immunol; 2018; 9():2354. PubMed ID: 30369930
    [TBL] [Abstract][Full Text] [Related]  

  • 38. External validation of leukocytosis and neutrophilia as a prognostic marker in anal carcinoma treated with definitive chemoradiation.
    Schernberg A; Huguet F; Moureau-Zabotto L; Chargari C; Rivin Del Campo E; Schlienger M; Escande A; Touboul E; Deutsch E
    Radiother Oncol; 2017 Jul; 124(1):110-117. PubMed ID: 28662871
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Epithelial to mesenchymal transition and HPV infection in squamous cell oropharyngeal carcinomas: the papillophar study.
    Lefevre M; Rousseau A; Rayon T; Dalstein V; Clavel C; Beby-Defaux A; Pretet JL; Soussan P; Polette M; Lacau Saint Guily J; Birembaut P;
    Br J Cancer; 2017 Jan; 116(3):362-369. PubMed ID: 28072763
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The prevalence of human papillomavirus in oropharyngeal cancer is increasing regardless of sex or race, and the influence of sex and race on survival is modified by human papillomavirus tumor status.
    Faraji F; Rettig EM; Tsai HL; El Asmar M; Fung N; Eisele DW; Fakhry C
    Cancer; 2019 Mar; 125(5):761-769. PubMed ID: 30521092
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.